Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685698 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
A Phase 2 study of Diabetic Foot Infections, sponsored by TaiGen Biotechnology Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 16
- Study locations
NCT00685698: Completed Phase 2 study of Diabetic Foot Infections, sponsored by TaiGen Biotechnology Co..
NCT00685698 is a Phase 2 study of Diabetic Foot Infections that has completed, run by TaiGen Biotechnology Co.. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). The trial reports 16 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685698, a Phase 2 study of Diabetic Foot Infections, has completed, sponsored by TaiGen Biotechnology Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 16
- Study locations
Study Summary
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
Primary Outcome
Clinical Success * Resolution is defined as total resolution of all pretreatment clinically significant signs and symptoms of infection and no development of any systemic evidence of infection. * Improvement is defined as resolution of more than two, but not all, pretreatment clinical signs and symptoms, or partial resolution of all clinical signs and symptoms relative to the baseline assessment, with no further need for antibiotic therapy, and no need for infection-related surgical interventio
Conditions Studied
Interventions
- DRUG TG-873870 (Nemonoxacin)
Study Locations (16)
Other
- Chang Gung Memorial Hospital- Kaoshiung, Taiwan - Kaohsiung City
- Cheng Ching Hospital, Taichung, Taiwan - Taichung
- Chi-Mei Medical Center, Tainan, Taiwan - Tainan
- Cardinal Tien Hospital (CTH), Taiwan - Taipei
- Tri-Service General Hospital, Taipei, Taiwan - Taipei
- Wan Fang Hospital - Taipei
- Cheng-Gung Memorial Hospital - LinKou, Taiwan - Taoyuan District
- Faculty of Medicine, Khon Kaen University - Khon Kaen
Gauteng
- Eastmed Academic Clinical Trial Center - East Lynne
- Jubilee Clinical Trial Center - Hammanskraal
- Montana Hospital - Pretoria
- Park Medical Center - Witbank
California
- HealthCare Partners - Montebello
- HealthCare Partners - Pasadena
Iowa
- The Amputation Prevention Center at Broadlawns Medical Center - Des Moines
Port Elizabeth
- Mercantile Clinical Trial Center - Korsten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
What the finished NCT00685698 record still lists
NCT00685698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Diabetic Foot Infections appearing as the primary indexed condition, and to 1 intervention - of which TG-873870 (Nemonoxacin) is the first listed.
NCT00685698 lists 16 locations in 5 states (Other, Gauteng, California).
Frequently Asked Questions
What is clinical trial NCT00685698 about?
NCT00685698 is a clinical study titled "Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections". Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
What is the current status of trial NCT00685698?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2008-06. Estimated completion is 2009-06.
What conditions does trial NCT00685698 study?
This clinical trial studies the following conditions: Diabetic Foot Infections.
What interventions are being tested in trial NCT00685698?
The interventions under investigation include: TG-873870 (Nemonoxacin) (DRUG).
Who is sponsoring clinical trial NCT00685698?
This trial is sponsored by TaiGen Biotechnology Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00685698 being conducted?
This trial has 16 study locations across California, Iowa, Gauteng, Port Elizabeth. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00685698's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia